Cargando…
A new perspective on mesenchymal stem cell-based therapy for liver diseases: restoring mitochondrial function
Mesenchymal stem cells (MSCs) have emerged as a promising alternative treatment for liver disease due to their roles in regeneration, fibrosis inhibition, and immunoregulation. Mitochondria are crucial in maintaining hepatocyte integrity and function. Mitochondrial dysfunction, such as impaired synt...
Autores principales: | Cen, Yelei, Lou, Guohua, Qi, Jinjin, Zheng, Min, Liu, Yanning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436412/ https://www.ncbi.nlm.nih.gov/pubmed/37596671 http://dx.doi.org/10.1186/s12964-023-01230-0 |
Ejemplares similares
-
Adipose-Derived Mesenchymal Stem Cells Inhibit JNK-Mediated Mitochondrial Retrograde Pathway to Alleviate Acetaminophen-Induced Liver Injury
por: Cen, Yelei, et al.
Publicado: (2023) -
Selonsertib, a potential drug for liver failure therapy by rescuing the mitochondrial dysfunction of macrophage via ASK1–JNK–DRP1 pathway
por: Lou, Guohua, et al.
Publicado: (2021) -
Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases
por: Lou, Guohua, et al.
Publicado: (2017) -
MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis
por: Lou, Guohua, et al.
Publicado: (2017) -
MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway
por: Lou, Guohua, et al.
Publicado: (2020)